HCPCS J0791 — Inj crizanlizumab-tmca 5mg (2026 RVU Values)

HCPCS code J0791 (Inj crizanlizumab-tmca 5mg) is published in the 2026 CMS Physician Fee Schedule. Use this page as a reference for billing, productivity tracking, and compensation modeling.

Related references